Heidelberg Pharma Digital develops antibody-drug conjugate development platforms and digital preclinical analytics for its proprietary ATAC technology in cancer treatment drug development.
Heidelberg Pharma Digital develops antibody-drug conjugate development platforms and digital preclinical analytics for its proprietary ATAC technology in cancer treatment drug development.